Transforming growth factor-beta: a clinical target for the treatment of diabetic nephropathy (Q28292776)

The extracellular matrix in diabetic nephropathy

Europe PubMed Central

title

Transforming growth factor-beta: a clinical target for the treatment of diabetic nephropathy (English)

0 references

1 reference

Tracy A McGowan

1

0 references

Yanqing Zhu

series ordinal

2

0 references

Kumar Sharma

series ordinal

3

0 references

language of work or name

English

0 references

publication date

December 2004

0 references

published in

Current diabetes report

0 references

volume

4

0 references

issue

6

0 references

page(s)

447-54

0 references

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11892-004-0055-Z

Progression of chronic kidney disease: the role of blood pressure control, proteinuria, and angiotensin-converting enzyme inhibition: a patient-level meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-004-0055-Z

Involvement of transforming growth factor-beta in regulation of calcium transients in diabetic vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-004-0055-Z

Antihypertensive effects of chronic anti-TGF-beta antibody therapy in Dahl S rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-004-0055-Z

Diabetic kidney disease in thedb/dbmouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-004-0055-Z

Glucose stimulation of transforming growth factor-beta bioactivity in mesangial cells is mediated by thrombospondin-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-004-0055-Z

Natural inhibitor of transforming growth factor-β protects against scarring in experimental kidney disease

21 January 2018

1 reference

12 December 2020

Interstitial pathomechanisms underlying progressive tubulointerstitial damage

1 reference

12 December 2020

Add-on angiotensin II receptor blockade lowers urinary transforming growth factor-beta levels

1 reference

12 December 2020

Urinary transforming growth factor-beta excretion in patients with hypertension, type 2 diabetes, and elevated albumin excretion rate: effects of angiotensin receptor blockade and sodium restriction

1 reference

12 December 2020

Pharmacokinetics of an antifibrotic agent, pirfenidone, in haemodialysis patients.

1 reference

12 December 2020

Cyclic stretching force selectively up-regulates transforming growth factor-beta isoforms in cultured rat mesangial cells

1 reference

12 December 2020

Effect of pirfenidone against vanadate-induced kidney fibrosis in rats

1 reference

12 December 2020

The effects of smoking and its cessation on 8-epi-PGF2alpha and transforming growth factor-beta 1 in Type 1 diabetes mellitus.

1 reference

12 December 2020

Neutralization of TGF-beta by anti-TGF-beta antibody attenuates kidney hypertrophy and the enhanced extracellular matrix gene expression in STZ-induced diabetic mice

1 reference

12 December 2020

Retardation of phenotypic transition of rabbit arterial smooth muscle cells in three-dimensional primary culture

1 reference

12 December 2020

Amelioration of doxorubicin-induced cardiac and renal toxicity by pirfenidone in rats

1 reference

12 December 2020

Transforming growth factor-beta function blocking prevents myocardial fibrosis and diastolic dysfunction in pressure-overloaded rats

1 reference

12 December 2020

Is Smad3 a major player in signal transduction pathways leading to fibrogenesis?

1 reference

12 December 2020

Quantification of glomerular TGF-beta 1 mRNA in patients with diabetes mellitus

1 reference

12 December 2020

Expression of transforming growth factor beta is elevated in human and experimental diabetic nephropathy

1 reference

12 December 2020

Combination treatment of angiotensin-II receptor blocker and angiotensin-converting-enzyme inhibitor in non-diabetic renal disease (COOPERATE): a randomised controlled trial

1 reference

12 December 2020

Renal hypertrophy is associated with upregulation of TGF-beta 1 gene expression in diabetic BB rat and NOD mouse

1 reference

12 December 2020

Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor-beta antibody in db/db diabetic mice

1 reference

12 December 2020

Expression of transforming growth factor-beta and type IV collagen in early streptozotocin-induced diabetes

1 reference

12 December 2020

Divergent effects of low versus high dose anti-TGF-beta antibody in puromycin aminonucleoside nephropathy in rats

1 reference

12 December 2020

Transforming growth factor-beta2 antibody attenuates fibrosis in the experimental diabetic rat kidney

1 reference

12 December 2020

The emerging role of transforming growth factor-beta in kidney diseases

1 reference

12 December 2020

Stimulation of collagen gene expression and protein synthesis in murine mesangial cells by high glucose is mediated by autocrine activation of transforming growth factor-beta

1 reference

12 December 2020

Acute and chronic renal effects of recombinant human TGF-beta2 in the rat.

1 reference

12 December 2020

Expression of transforming growth factor-beta isoforms in human glomerular diseases

1 reference

12 December 2020

Renal fibrosis in mice treated with human recombinant transforming growth factor-beta2

1 reference

12 December 2020

Effect of pirfenidone on the pulmonary fibrosis of Hermansky-Pudlak syndrome

1 reference

12 December 2020

Mesangial expansion as a central mechanism for loss of kidney function in diabetic patients

1 reference

12 December 2020

Circulating and urinary transforming growth factor beta1, Amadori albumin, and complications of type 1 diabetes: the EURODIAB prospective complications study

1 reference

12 December 2020

1 reference

12 December 2020

Dietary protein restriction rapidly reduces transforming growth factor beta 1 expression in experimental glomerulonephritis

1 reference

12 December 2020

Targeted disruption in murine cells reveals variable requirement for Smad4 in transforming growth factor beta-related signaling.

1 reference

12 December 2020

Structural-functional relationships in diabetic nephropathy

1 reference

12 December 2020

In vivo inhibition of rat stellate cell activation by soluble transforming growth factor beta type II receptor: a potential new therapy for hepatic fibrosis

1 reference

12 December 2020

Pirfenidone treatment decreases transforming growth factor-beta1 and matrix proteins and ameliorates fibrosis in chronic cyclosporine nephrotoxicity

1 reference

12 December 2020

Cell and matrix components of the glomerular mesangium in type I diabetes

1 reference

12 December 2020

Hyperglycemia and diabetic kidney disease. The case for transforming growth factor-beta as a key mediator

1 reference

12 December 2020

Effects of pirfenidone on transforming growth factor-beta gene expression at the transcriptional level in bleomycin hamster model of lung fibrosis

1 reference

12 December 2020

Intervention with tranilast attenuates renal pathology and albuminuria in advanced experimental diabetic nephropathy

1 reference

12 December 2020

Diabetic nephropathy and transforming growth factor-beta: transforming our view of glomerulosclerosis and fibrosis build-up

1 reference

12 December 2020

Add-on anti-TGF-beta antibody to ACE inhibitor arrests progressive diabetic nephropathy in the rat.

1 reference

12 December 2020

Reversibility of established diabetic glomerulopathy by anti-TGF-beta antibodies in db/db mice.

1 reference

12 December 2020

Effect of aldosterone on renal transforming growth factor-beta

1 reference

12 December 2020

Role of Smad4 on TGF-beta-induced extracellular matrix stimulation in mesangial cells

1 reference

12 December 2020

Captopril-induced reduction of serum levels of transforming growth factor-beta1 correlates with long-term renoprotection in insulin-dependent diabetic patients

1 reference

12 December 2020

Global glomerular sclerosis and glomerular arteriolar hyalinosis in insulin dependent diabetes

1 reference

12 December 2020

Smad pathway is activated in the diabetic mouse kidney and Smad3 mediates TGF-beta-induced fibronectin in mesangial cells

1 reference

12 December 2020

Reversal of cardiac and renal fibrosis by pirfenidone and spironolactone in streptozotocin-diabetic rats

1 reference

12 December 2020

Effects of the combination of an angiotensin II antagonist with an HMG-CoA reductase inhibitor in experimental diabetes

1 reference

12 December 2020

Pirfenidone improves renal function and fibrosis in the post-obstructed kidney

1 reference

12 December 2020

Treatment of idiopathic pulmonary fibrosis with a new antifibrotic agent, pirfenidone: results of a prospective, open-label Phase II study

1 reference

12 December 2020

Pirfenidone reduces in vitro rat renal fibroblast activation and mitogenesis.

1 reference

12 December 2020

The recombinant proregion of transforming growth factor beta1 (latency-associated peptide) inhibits active transforming growth factor beta1 in transgenic mice.

1 reference

12 December 2020

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

1 reference

12 December 2020

Biochemical events and cytokine interactions linking glucose metabolism to the development of diabetic nephropathy

1 reference

12 December 2020

Lifetime exposure to a soluble TGF-beta antagonist protects mice against metastasis without adverse side effects

1 reference

12 December 2020

Glomerular cell number in normal subjects and in type 1 diabetic patients

1 reference

12 December 2020

Reversal of lesions of diabetic nephropathy after pancreas transplantation

1 reference

12 December 2020

Therapy with antisense TGF-beta1 oligodeoxynucleotides reduces kidney weight and matrix mRNAs in diabetic mice

1 reference

12 December 2020

Role of nitric oxide in antagonistic effects of transforming growth factor-beta and interleukin-1 beta on the beating rate of cultured cardiac myocytes

1 reference

12 December 2020

The renal hemodynamic basis of diabetic nephropathy

1 reference

12 December 2020

TGF-beta signaling in renal disease

1 reference

12 December 2020

Antifibrotic therapy for the treatment of pulmonary fibrosis

1 reference

12 December 2020

Functional characterization of transforming growth factor beta signaling in Smad2- and Smad3-deficient fibroblasts

1 reference

12 December 2020

Increased renal production of transforming growth factor-beta1 in patients with type II diabetes

1 reference

12 December 2020

The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group

1 reference

12 December 2020

Losartan decreases plasma levels of TGF-beta1 in transplant patients with chronic allograft nephropathy

1 reference

12 December 2020